Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

179.93
Delayed Data
As of May 28
 +0.51 / +0.28%
Today’s Change
131.69
Today|||52-Week Range
191.01
+9.89%
Year-to-Date
No recent news for Jazz Pharmaceuticals PLC.

Today’s Trading

Previous close179.42
Today’s open177.42
Day’s range-- - --
Volume274,459
Average volume (3 months)633,748
Market cap$11.0B
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-73.50%
Earnings growth (this year)+14.71%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+34.44%
P/E ratio51.7
Price/Sales8.34
Price/Book7.94

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+0.42+0.32%
RDYDr.Reddy's Laborator...-0.34-0.61%
ALKSAlkermes Plc-0.65-1.07%
UTHRUnited Therapeutics ...-1.61-0.88%
Data as of 05/28/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$2.42
Annual revenue (last year)$1.2B
Annual profit (last year)$58.4M
Net profit margin4.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers